RhumbLine Advisers

RhumbLine Advisers’s Scinai Immunotherapeutics SCNI Stock Holding History

RhumbLine Advisers’s Portfolio SCNI Stock Details SCNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.49K	Buy
2025 Q2	$7.97K	Buy
2025 Q1	$4.17K	Sell
2024 Q4	$5.5K	Hold
2024 Q3	$5.85K	Buy
2024 Q2	$3.24K	Buy
2024 Q1	$3.44K	Buy
2023 Q4	$3.08K	Buy
2023 Q3	$3.08K	Buy
2023 Q2	$4.76K	Buy